Xigen

Biopharma, Biotechnology, Therapeutics
Founded in 2002-01-01
Epalinges, Vaud, Switzerland
http://www.xigenpharma.com
For Profit

About Xigen

Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decade's research expertise on intracellular peptides and signalling.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 6 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 41000000 USD
  • Last Funding: 20000000 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Xigen actively uses 6 products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Therapeutics

Headquarters: Epalinges, Vaud, Switzerland